Pillstats
Rx only · Injection, Powder, Lyophilized, For Solution · Intravenous

Mycophenolate Mofetil

Mycophenolate Mofetil

5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US5 NDCs
5 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)68149
US makers5 labelers
Packages6
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

n/a102030402025 Q12025 Q22025 Q32025 Q42026 Q1
24
Rx · 2025 Q4
364
Units dispensed
4
Quarters · since 2025 Q1

Who makes it5 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Meitheal Pharmaceuticals Inc.unknown2SUPPLYING
Mylan Institutional LLCunknown1SUPPLYING
Armas Pharmaceuticals Inc.unknown1SUPPLYING
Par Health USA, LLCunknown1SUPPLYING
ONESOURCE SPECIALTY PHARMA LIMITEDunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 30, 2019
    RECALLRecall (Class I): Mycophenolate Mofetil for Injection, USP 500 mg, 4 Single Dose Vials, Rx Only, Distributed by: Par Pharmaceutical Ches…

    Presence of Particulate Matter; glass fragment observed in one vial of reconstituted product — Recalling firm: Par Pharmaceutical, Inc. — nationwide